MAP kinase activation increases Mcl-1 expression leading to cell survival, implicating the role of Mcl-1 in apoptotic cancer cell evasion and breast cancer therapeutic resistance (Williams and Cook, 2015). The gene discussed is MCL1; the disease is breast carcinoma.